New Analysis Challenges Tamiflu Efficacy (CME/CE)

Courtesy MedPage Today Infectious Disease  Tue, 01/17/2012 - 17:35

(MedPage Today) -- A new review of the influenza drug oseltamivir (Tamiflu) has raised questions about both the efficacy of the medication and the commitment of its maker to supply enough data for claims about the drug to be evaluated by independent experts.


 

More related items

New Concentration for Flu Drug
WASHINGTON (MedPage Today) -- Oseltamivir (Tamiflu) oral suspension will be marketed in a new 6 mg/mL concentration to reduce prescribing and dosing errors, the FDA announced Monday.

FDA Warns Consumers About Fake Tamiflu Online
WASHINGTON (MedPage Today) -- The FDA warned consumers Thursday to be alert for websites selling a fake "generic" version of the flu drug oseltamivir (Tamiflu), which may be dangerous to...

New Anti-Flu Drug Matches Oseltamivir (CME/CE)
SAN FRANCISCO (MedPage Today) -- In a head-to-head trial, an investigational drug to combat influenza was equivalent to oseltamivir (Tamiflu), a researcher said here.

Numi's Bouquet Bamboo Gift Set with Clear Teapot and...

Mania By Giorgio Armani For Men. Eau De Toilette...
Mania Was Created For The Man Seeking A Discreet, Elegant, And Classic Signature Scent. The Classical Freshness Of Mania Is Built Around A Sensual Amber-woody Accord That Brings To Mind Warm...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com